二甲双胍中毒体外治疗管理指南的回顾性评价
该单中心回顾性分析纳入201例疑似二甲双胍中毒且乳酸>5 mmol/L、pH<7.35或肾功能受损的患者,按EXTRIP标准分为EXTRIP阳性145例和阴性56例。EXTRIP阳性患者中96例接受体外清除、49例未接受,两组生存率分别为75.0%和73.5%(P>0.05)。未满足EXTRIP标准的56例全部存活,阴性预测值100%。研究未证明体外清除对满足EXTRIP标准者有生存获益,作者认为需进一步研究。
要点
- 201例二甲双胍中毒患者中,145例满足EXTRIP推荐标准,56例不满足。
- 满足EXTRIP标准者接受体外清除96例与未接受49例,生存率分别为75.0%和73.5%(P>0.05),无差异。
- 未满足EXTRIP标准的56例患者全部存活,阴性预测值100%。
- 该单中心回顾性分析未显示体外清除在满足EXTRIP标准患者中的生存获益。
- 作者认为需进一步研究评估满足EXTRIP标准者体外清除的获益。
适用人群与场景
- 疑似二甲双胍中毒且至少满足以下一项:乳酸浓度>5 mmol/L;pH<7.35;肾功能受损。
诊断标准与关键阈值
- EXTRIP工作组标准用于判定二甲双胍中毒患者是否需体外清除毒素。
- 本研究纳入标准:疑似二甲双胍中毒且乳酸>5 mmol/L、pH<7.35或肾功能受损。
研究设计与关键结果
- 单中心回顾性分析纳入201例二甲双胍中毒患者,145例满足EXTRIP推荐标准(EXTRIP阳性),56例不满足(EXTRIP阴性)。
- EXTRIP阳性患者中96例接受体外清除、49例未接受,生存率分别为75.0%和73.5%(P>0.05)。
- EXTRIP阴性56例患者全部存活,阴性预测值100%。
- 以EXTRIP标准和生存计算的敏感性、特异性、阴性预测值、阳性预测值见原文。
证据类型、等级与局限
- 证据类型:单中心回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究未显示满足EXTRIP标准的二甲双胍中毒患者接受体外清除有生存获益。
- 未满足EXTRIP标准的患者全部存活,阴性预测值100%。
- 作者认为需进一步研究评估满足EXTRIP标准者体外清除的获益。
指南或共识出处
- EXTRIP(Extracorporeal Treatments in Poisoning)工作组标准;原文发表于Clin Toxicol (Phila)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup defined criteria for extracorporeal toxin removal in patients with metformin poisoning. The primary objective of this study was to determine the benefit of extracorporeal toxin removal in patients meeting EXTRIP criteria. The secondary objective was to determine the performance characteristics of the EXTRIP criteria.
METHODS: This was a single-center retrospective analysis of metformin poisoned patients. Inclusion criteria were: suspicion of metformin poisoning with at least one of the following present: lactate concentration >5 mmol/L; pH < 7.35; or impaired kidney function. Patient data were extracted by reviewers who were unaware of the study hypothesis. Cases were analyzed based on EXTRIP criteria, whether extracorporeal toxin removal was performed, and survival. Sensitivity, specificity, negative predictive value and positive predictive value were calculated with respect to the EXTRIP criteria and survival.
RESULTS: Of 201 patients studied, 145 patients met recommended EXTRIP criteria (EXTRIP positive) and 56 patients did not (EXTRIP negative). Among patients who met recommended EXTRIP criteria, 96 received extracorporeal toxin removal and 49 did not. There was no difference in survival between these groups: 75.0% versus 73.5%, respectively (P >0.05). All 56 patients who did not meet EXTRIP criteria, survived (negative predictive value = 100%).
DISCUSSION: The study did not demonstrate a survival benefit for extracorporeal toxin removal in those meeting EXTRIP criteria.
CONCLUSION: In this retrospective analysis, the recommended EXTRIP criteria had a negative predictive value for death of 100%. Further study is needed to evaluate the benefit of extracorporeal toxin removal in patients meeting EXTRIP criteria for metformin poisoning.
参考来源
- Trebach J, Mohan S, Gnirke M, et al. Retrospective evaluation of management guidelines for extracorporeal treatment of metformin poisoning. Clin Toxicol (Phila). 2023. PMID: 36752699. doi:10.1080/15563650.2022.2156880
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。